Back to SSA Adult Listings Overview

Hematological disorders encompass a wide range of conditions affecting the blood’s ability to perform essential functions, such as oxygen transport, clotting, and fighting infections. The Social Security Administration (SSA) recognizes the significant impact these disorders can have on individuals’ lives, including those living in Denver, Colorado, and has specific criteria for evaluating these conditions for disability benefits.

Key Hematological Disorders Evaluated by the SSA

The SSA evaluates both non-malignant and malignant hematological disorders. Non-malignant disorders include:

  • Hemolytic anemias, such as sickle cell disease and thalassemia
  • Disorders of thrombosis and hemostasis, including clotting and bleeding disorders
  • Bone marrow failure disorders, such as myelodysplastic syndromes and aplastic anemia

Malignant disorders, such as lymphoma, leukemia, and multiple myeloma, are evaluated under the appropriate listings in section 13.00, with specific considerations for lymphomas associated with HIV infection.

Recent Revisions to Evaluation Criteria

The SSA’s revisions to the criteria for evaluating hematological disorders reflect advances in medical knowledge, diagnosis, and treatment. These changes aim to ensure that the listings accurately represent the current state of medical understanding and treatment practices, helping individuals with hematological disorders receive the support they need.

Required Evidence for Evaluation

To document a hematological disorder, the SSA requires:

  • A laboratory report of a definitive test establishing the disorder, signed by a physician
  • A physician’s report stating the individual has the disorder if a signed laboratory report is not available
  • In the absence of a definitive laboratory test, a persuasive report from a physician confirming the diagnosis through appropriate laboratory analysis or other diagnostic methods

The SSA makes every effort to obtain the results of appropriate laboratory testing and does not require patients to undergo complex, costly, or invasive tests.

Evaluating Hematological Disorders

Hematological disorders are evaluated based on their impact on an individual’s ability to perform substantial gainful activity. The SSA considers the severity and frequency of complications, the need for hospitalization, and the functional limitations caused by the disorder and its treatment. For Denver and Colorado residents, this means that the unique challenges posed by hematological disorders are recognized and considered in the disability determination process.

The Importance of Staying Informed

For individuals with hematological disorders, staying informed about the SSA’s evaluation criteria and ensuring comprehensive medical documentation is crucial. Legal professionals specializing in SSA disability benefits can provide invaluable assistance, guiding individuals through the application process and helping to present a strong case for their claim.

Remember, navigating the complexities of SSA disability benefits for hematological disorders can be challenging, but with the right support and guidance, individuals can secure the benefits they need to manage their condition and improve their quality of life.